Patents by Inventor Mélanie Saville

Mélanie Saville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10946087
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: March 16, 2021
    Assignee: SANOFI PASTEUR
    Inventors: Nadia Tornieporth, Alain Bouckenooghe, Fernando Noriega, Melanie Saville, Nicholas Jackson, Yves Girerd-Chambaz
  • Patent number: 10857222
    Abstract: The present invention relates to a yellow fever (YF) vaccine for use in a method for inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said yellow fever vaccine to a human subject together with a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4. This invention also pertains to a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4 for use in a method of inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said tetravalent dengue vaccine to a human subject together with a yellow fever (YF) vaccine.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: December 8, 2020
    Assignee: SANOFI PASTEUR
    Inventors: Fernando Noriega, Betzana Zambrano, Nadia Tornieporth, Mélanie Saville, Eric Plennevaux, Mark Boaz, Thomas Papa
  • Publication number: 20190201517
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: September 6, 2018
    Publication date: July 4, 2019
    Applicant: SANOFI PASTEUR
    Inventors: Alain Bouckenooghe, Remi Forrat, Jean Lang, Mélanie Saville, Nadia Tornieporth
  • Publication number: 20180193447
    Abstract: The present invention relates to a yellow fever (YF) vaccine for use in a method for inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said yellow fever vaccine to a human subject together with a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4. This invention also pertains to a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4 for use in a method of inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said tetravalent dengue vaccine to a human subject together with a yellow fever (YF) vaccine.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 12, 2018
    Inventors: Fernando Noriega, Betzana Zambrano, Nadia Tornieporth, Mélanie Saville, Eric Plennevaux, Mark Boaz, Thomas Papa
  • Publication number: 20170304426
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 26, 2017
    Applicant: Sanofi Pasteur
    Inventors: Nadia Tornieporth, Alain Bouckenooghe, Fernando Noriega, Melanie Saville, Nicholas Jackson
  • Publication number: 20150196631
    Abstract: The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.
    Type: Application
    Filed: July 24, 2013
    Publication date: July 16, 2015
    Applicant: Sanofi Pasteur
    Inventors: Alain Bouckenooghe, Remi Forrat, Jean Lang, Mélanie Saville, Nadia Tornieporth